NorthStar signs exclusive radioisotope distribution, marketing agreement with GE Healthcare

NorthStar Medical Radioisotopes has signed an exclusive agreement with GE Healthcare Systems to market and distribute Iodine-123 (I-123), a radioisotope used routinely in nuclear medicine, the Beloit-based radiopharmaceutical company announced today. Under the terms of the contract, GE Healthcare Systems’ Pharmaceutical Diagnostics unit will manufacture I-123 capsules at its production facility in Arlington Heights, Illinois.

Already a subscriber? Log in

To continue reading this article ...

Subscribe to BizTimes today and get immediate access to our Insider-only content and much more.

Learn More and Subscribe Now

Sign up for the BizTimes email newsletter

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

What's New

BizPeople

Sponsored Content

Holiday flash sale!

Limited time offer. New subscribers only.

Subscribe to BizTimes Milwaukee and save 40%

Holiday flash sale! Subscribe to BizTimes and save 40%!

Limited time offer. New subscribers only.